Imunon, Inc.

IMNN·NasdaqCM·Healthcare
Compare
0.9070+0.0070 (+0.78%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.9000
Open0.9700
Day range0.88020.9789
52-week range0.81004.3800
Off day high−7.34%
Off 52-week high−79.29%
Volume21.97K
Avg. volume (3M)108.18K
Market cap5.09M
EPS (TTM)-3.84
Forward P/E-0.51
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)2.08
Shares outstanding5.61M
Short interest1.12% of float
Earnings dateAug 12, 2025 (est.)
Analyst target17.0000
Profit margin0.00%

Against its peers

Compare in full ›
IMNN AIM IMU.AX ATORX.ST APVO TOVX
Market cap 5.09M 6.42M 19.39M 38.89M 2.90M 8.72M
P/E (TTM) — — — — 0.0 0.3
Forward P/E -0.5 -0.4 -0.9 -0.1 -0.1 -1.0
Price/book 2.2 0.6 1.6 0.3 0.3 0.7
Dividend yield — — — — — —
1-year change −77.02% −90.12% −91.04% −99.41% −94.72% −29.63%
Today +0.78% +0.19% +16.67% +1.87% +0.74% +4.40%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.

Latest news

All IMNN news ›
markets.businessinsider.com·Positive

IMUNON to Participate in Upcoming Investor Conferences

LAWRENCEVILLE, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage biotechnology company developing DNA-mediat... IMUNON to Participate in Upcoming Investor Conferences LAWRENCEVILLE, N.J., Oct. 08, 2026…

markets.businessinsider.com·Positive

IMUNON Converts $1.2 Million of Debt-to-Equity

Unique investment vehicle provides efficient access to equity capitalOutstanding debt of the original Note lowered by approximately 43% No issuanc... IMUNON Converts $1.2 Million of Debt-to-Equity Unique investment vehicle provides…

ITWeb·Positive

iOCO CEO draws no base salary, CFO earns R10.6m

iOCO group chief financial officer Ashona Kooblall received total remuneration of R10.61 million for the 2026 financial year, while group CEO Rhys Summerton received no base salary. This is according to the technology services group’s…

Stock Titan·

Imunon CEO Stacy Lindborg receives 2,977-share grant

Imunon (IMNN) grants its CEO 2,977 shares in lieu of cash for part of her base salary. Stock Titan Imunon CEO Stacy Lindborg receives 2,977-share grant Her reported post-award holdings included 116,174 directly held shares and 778 shares…

Stock Titan·

Imunon chairman acquires 7,800 shares as salary

Stock replaces cash salary as Imunon (IMNN) chairman acquires 7,800 shares at $1.08 each. Stock Titan Imunon chairman acquires 7,800 shares as salary The executive chairman also reported an indirect holding of 4,622 shares held by IRA.…

Stock Titan·

Imunon grants medical chief 1,249 shares as salary

At $1.08 a share, Imunon (IMNN) grants its medical chief 1,249 shares in place of cash salary. Stock Titan Imunon grants medical chief 1,249 shares as salary Imunon, Inc. Chief Medical Officer Douglas Vincent Faller acquired 1,249 shares…

markets.businessinsider.com·Positive

IMUNON Announces Strategic Sale of ThermoDox®

Agreement with VoxelDox Therapeutics, Inc. Creates a Clear Path to Future Value, Subject to Achievement of Development Milestones in the Planned P... IMUNON Announces Strategic Sale of ThermoDox® Agreement with VoxelDox Therapeutics, Inc.…

From the 4Search news index, newest first.

In the news

14mentions in 30 days
13with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 14 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance